Colleen R Kelly Selected Research

Fecal Microbiota Transplantation

1/2022	Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation.
1/2022	Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study.
1/2021	Management of Severe and Severe/Complicated Clostridoides difficile Infection Using Sequential Fecal Microbiota Transplant by Retention Enema.
1/2021	Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
1/2021	Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
1/2021	Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection.
11/2020	Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
1/2020	Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
1/2020	Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant.
1/2019	Manipulating the Microbiome With Fecal Transplantation to Treat Ulcerative Colitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Colleen R Kelly Research Topics

Disease

26	Clostridium Infections 01/2022 - 02/2012
6	Infections 01/2022 - 10/2015
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 08/2013
5	Ulcerative Colitis 07/2019 - 08/2013
3	Diarrhea 11/2016 - 08/2013
1	Alopecia (Baldness) 01/2017
1	Dysbiosis 01/2016
1	Weight Gain 01/2015
1	Reinfection 08/2013
1	Adenoma (Adenomas) 02/2003
1	Colorectal Neoplasms (Colorectal Cancer) 02/2003
1	Neoplasms (Cancer) 02/2003
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2003
1	Neoplasm Metastasis (Metastasis) 02/2003

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2014
2	acceleratory factor from growth hormone (AcG)IBA 01/2022 - 01/2021
2	Metronidazole (Metric)FDA LinkGeneric 01/2018 - 08/2013
2	Vancomycin FDA LinkGeneric 08/2013 - 02/2012
1	Bile Acids and Salts (Bile Acids)IBA 12/2016
1	Investigational DrugsIBA 02/2014
1	ProstaglandinsIBA 02/2003
1	Proteins (Proteins, Gene)FDA Link 02/2003
1	Antineoplastic Agents (Antineoplastics)IBA 02/2003
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2003
1	Interleukin-10 (Interleukin 10)IBA 02/2003
1	Interleukin-12 (IL 12)IBA 02/2003
1	Cyclin D1IBA 02/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2003
1	rofecoxib (Vioxx)FDA Link 02/2003
1	beta CateninIBA 02/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2003
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2003

Therapy/Procedure

24	Fecal Microbiota Transplantation 01/2022 - 02/2012
8	Therapeutics 01/2021 - 02/2014
5	Transplantation 01/2020 - 07/2019
1	Enema (Enemas) 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Donor Selection 07/2019
1	Length of Stay 10/2015
1	Colectomy 07/2014